Announcement – Mitsubishi Tanabe Pharma Canada

The first new therapy for ALS in a generation, Radicava (edaravone), has won approval in Canada!

Health Canada has approved a new ALS drug that is showing potential to slow progress of the fatal disease.
Generically known as Edaravone, its brand name is Radicava and it’s the first promising ALS drug to be approved in Canada in almost 20 years. Canada is the fourth country to approve the drug, after Japan, South Korea and the U.S.

Read more